Schmid CW and PL Deininger. (1975). Sequence organization of the human genome. Cell 6:345-358.
Warburton PE, D Hasson, F Guillem, C Lescale, X Jin and G Abrusan. (2008). Analysis of the largest tandemly repeated DNA families in the human genome. BMC Genomics 9:533.
Wijmenga C, JE Hewitt, LA Sandkuijl, LN Clark, TJ Wright, HG Dauwerse, et al. (1992). Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 2:26-30.
Hewitt JE, R Lyle, LN Clark, EM Valleley, TJ Wright, C Wijmenga, et al. (1994). Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 3:1287-1295.
Van Geel M, MC Dickson, AF Beck, DJ Bolland, RR Frants, SM van der Maarel, et al. (2002). Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. Genomics 79:210-217.
Gabriëls J, MC Beckers, H Ding, A De Vriese, S Plaisance, SM van der Maarel, et al. (1999). Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 236:25-32.
Ding H, MC Beckers, S Plaisance, P Marynen, D Collen and A Belayew. (1998). Characterization of a double homeodomain protein (DUX1) encoded by a cDNA homologous to 3.3 kb dispersed repeated elements. Hum Mol Genet 7:1681-1694.
Jones TI, JCJ Chen, F Rahimov, S Homma, P Arashiro, ML Beermann, et al. (2012). Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum Mol Genet 21:4419-4430.
Dixit M, E Ansseau, A Tassin, S Winokur, R Shi, H Qian, et al. (2007). DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A 104:18157-18162.
Kowaljow V, A Marcowycz, E Ansseau, CB Conde, S Sauvage, C Mattéotti, et al. (2007). The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul Disord 17:611-623.
Lemmers RJLF, PJ van der Vliet, R Klooster, S Sacconi, P Camanõ, JG Dauwerse, et al. (2010). A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329:1650-1653.
Richards M, F Coppée, N Thomas, A Belayew and M Upadhyaya. (2012). Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Hum Genet 131:325-340.
Tawil R, SM van der Maarel and SJ Tapscott. (2014). Facioscapulohumeral dystrophy: the path to consensus on pathophysiology. Skelet Muscle 4:12.
De Greef JC, RJLF Lemmers, BGMvan Engelen, S Sacconi, SL Venance, RR Frants, et al. (2009). Common epigenetic changes of D4Z4 in contraction-dependent and contractionindependent FSHD. Hum Mutat 30:1449-1459.
De Greef JC, Lemmers RJLF, P Camanõ, JW Day, S Sacconi, M Dunand, et al. (2010). Clinical features of facioscapulohumeral muscular dystrophy 2. Neurology 75:1548-1554.
Winston J, L Duerden, M Mort, IM Frayling, MT Rogers and M Upadhyaya. (2014). Identification of two novel SMCHD1 sequence variants in families with FSHD-like muscular dystrophy. Eur J Hum Genet 23:67-71.
Lemmers RJLF, JJ Goeman, PJ van der Vliet, MP van Nieuwenhuizen, J Balog, M Vos-Versteeg, et al. (2014). Inter-individual differences in CpG methylation at D4Z4 correlate with clinical variability in FSHD1 and FSHD2. Hum Mol Genet 24:659-669.
Sacconi S, RJLF Lemmers, J Balog, PJ van der Vliet, P Lahaut, MP van Nieuwenhuizen, et al. (2013). The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1. Am J Hum Genet 93: 744-751.
Snider L, LN Geng, RJLF Lemmers, M Kyba, CB Ware, AM Nelson, et al. (2010). Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet 6:e1001181.
Tassin A, D Laoudj-Chenivesse, C Vanderplanck, M Barro, S Charron, E Ansseau, et al. (2013). DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy? J Cell Mol Med 17:76-89.
Bosnakovski D, Z Xu, EJ Gang, CL Galindo, M Liu, T Simsek, et al. (2008). An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J 27:2766-2779.
Geng LN, Z Yao, L Snider, AP Fong, JN Cech, JM Young, et al. (2012). DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell 22:38-51.
Young JM, JL Whiddon, Z Yao, B Kasinathan, L Snider, LN Geng, et al. (2013). DUX4 binding to retroelements creates promoters that are active in FSHD muscle and testis. PLoS Genet 9:e1003947.
Sharma V, N Harafuji, A Belayew and Y-W Chen. (2013). DUX4 differentially regulates transcriptomes of human rhabdomyosarcoma and mouse C2C12 cells. PLoS One 8:e64691.
Yao Z, L Snider, J Balog, RJLF Lemmers, SM van der Maarel, R Tawil, et al. (2014). DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Hum Mol Genet 23:5342-5352.
Wallace LM, SE Garwick, W Mei, A Belayew, F Coppee, KJ Ladner, et al. (2011). DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol 69:540-552.
Vanderplanck C, E Ansseau, S Charron, N Stricwant, A Tassin, D Laoudj-Chenivesse, et al. (2011). The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS One 6:e26820.
Domire JS, LM Wallace, S Guckes, J Liu and SQ Harper. (2013). P.16.1 DUX4 regulates expression of the Pro-Apoptotic Gene, p63. Neuromuscul Disord 23:822.
Dandapat A, LM Hartweck, D Bosnakovski and M Kyba. (2013). Expression of the human FSHD-linked DUX4 gene induces neurogenesis during differentiation of murine embryonic stem cells. Stem Cells Dev 22:2440-2448.
Xu H, Z Wang, S Jin, H Hao, L Zheng, B Zhou, et al. (2014). Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression. Biochem Biophys Res Commun 446:235-240.
Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
Friedenstein AJ, RK Chailakhjan and KS Lalykina. (1970). The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393-403.
Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
Salem HK and C Thiemermann. (2010). Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28:585-596.
Meuleman N, T Tondreau, I Ahmad, J Kwan, F Crokaert, A Delforge, et al. (2009). Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: a pilot study. Stem Cells Dev 18:1247-1252.
Tondreau T, L Lagneaux, M Dejeneffe, A Delforge, M Massy, C Mortier, et al. (2004). Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential. Cytotherapy 6:372-379.
Mateizel I, N De Temmerman, U Ullmann, G Cauffman, K Sermon, H Van de Velde, et al. (2006). Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. Hum Reprod 21:503-511.
Mateizel I, C Spits, A Verloes, A Mertzanidou, I Liebaers and K Sermon. (2009). Characterization of CD30 expression in human embryonic stem cell lines cultured in serumfree media and passaged mechanically. Hum Reprod 24:2477-2489.
Mateizel I, C Spits, M De Rycke, I Liebaers and K Sermon. (2010). Derivation, culture, and characterization of VUB hESC lines. In Vitro Cell Dev Biol Anim 46:300-308.
Mateizel I, A De Becker, H Van de Velde, M De Rycke, A Van Steirteghem, R Cornelissen, et al. (2008). Efficient differentiation of human embryonic stem cells into a homogeneous population of osteoprogenitor-like cells. Reprod Biomed Online 16:741-753.
Snider L, A Asawachaicharn, AE Tyler, LN Geng, LM Petek, L Maves, et al. (2009). RNA transcripts, miRNAsized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum Mol Genet 18:2414-2430.
Fakhry M. (2013). Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World J Stem Cells 5:136.
Komori T. (2006). Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 99:1233-1239.
Qu B, O Liu, X Fang, H Zhang, Y Wang, H Quan, et al. (2014). Distal-less homeobox 2 promotes the osteogenic differentiation potential of stem cells from apical papilla. Cell Tissue Res 357:133-143.
Ortuno MJ, S Ruiz-Gaspa, E Rodriguez-Carballo, ARG Susperregui, R Bartrons, JL Rosa, et al. (2010). p38 Regulates Expression of Osteoblast-specific Genes by Phosphorylation of Osterix. J Biol Chem 285:31985-31994.
Nishio Y, Y Dong, M Paris, O'Keefe RJ, EM Schwarz and H Drissi. (2006). Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene. Gene 372:62-70.
Orimo H. (2010). The mechanism of mineralization and the role of alkaline phosphatase in health and disease. J Nippon Med Sch Nippon Ika Daigaku Zasshi.77:4-12.
Uccelli A, F Benvenuto, A Laroni and D Giunti. (2011). Neuroprotective features of mesenchymal stem cells. Best Pract Res Clin Haematol 24:59-64.
Lee J, AA Abdeen and KA Kilian. (2014). Rewiring mesenchymal stem cell lineage specification by switching the biophysical microenvironment. Sci Rep 4:5188.
